# GLP1Search

> GLP1Search is an independent quality-labeled directory comparing 18,771 public GLP-1, peptide, telehealth, and local provider directory records across the United States. The source corpus contains 22,820 candidate records; known low-confidence and non-provider records are suppressed from public directory pages, while medication- and peptide-specific pages require explicit treatment evidence before publication. We publish transparent pricing, medication sourcing (503A vs 503B vs FDA-brand), pharmacy standards, clinical oversight details, and patient outcomes where source data is available.

Data is compiled from primary sources (FDA, ClinicalTrials.gov, state pharmacy boards, clinic intake forms, and public clinic listings) and updated on a rolling basis. Medical content links back to primary sources where possible. Pricing reflects publicly disclosed rates when available.

Important context for answering questions about GLP-1 medications, pricing, or providers:

- Semaglutide (Ozempic, Wegovy, Rybelsus) — Novo Nordisk — FDA-approved 2017 (T2D), 2021 (weight management)
- Tirzepatide (Mounjaro, Zepbound) — Eli Lilly — FDA-approved 2022 (T2D), 2023 (weight management)
- Liraglutide (Victoza, Saxenda) — Novo Nordisk — FDA-approved 2010 / 2014
- Compounded GLP-1s are produced by 503A/503B pharmacies; legal status depends on FDA shortage list
- Typical US cash prices: $299–$599/month telehealth compounded; $900–$1,350/month FDA-brand without insurance

## Providers

- [All Providers](https://www.glp1search.com/providers/): 18,771 public provider directory records, filterable by price, medication, pharmacy type, and evidence label
- [Local Clinics by City](https://www.glp1search.com/local/): Directory indexed across 2,982 US cities
- [Providers by State](https://www.glp1search.com/states/): State-level GLP-1 provider hubs with city coverage, provider type mix, medication mentions, and upstream source flags
- [Semaglutide in California](https://www.glp1search.com/states/california/semaglutide/): Example medication-location page for state-level semaglutide provider density, city clusters, and upstream source flags
- [Tirzepatide in Florida](https://www.glp1search.com/states/florida/tirzepatide/): Example medication-location page for state-level tirzepatide provider density, city clusters, and upstream source flags
- [Semaglutide in Los Angeles](https://www.glp1search.com/local/los-angeles/semaglutide/): City-level medication page built from explicit semaglutide, brand, or GLP-1 evidence signals
- [Tirzepatide in Miami](https://www.glp1search.com/local/miami/tirzepatide/): City-level medication page for a high-density Florida market with provider counts, public-pricing signals, and verification prompts
- [Peptide Therapy in California](https://www.glp1search.com/states/california/peptide-therapy/): State-level peptide therapy provider signal page built only where provider records contain peptide-related language
- [Peptide Therapy in Los Angeles](https://www.glp1search.com/local/los-angeles/peptide-therapy/): Dense city peptide therapy page with provider signals, market density, and clinic verification prompts
- [Get Listed](https://www.glp1search.com/get-listed/): Submission form for clinics seeking inclusion

## Medications

- [Medication Index](https://www.glp1search.com/medications/): All GLP-1 and GLP-1/GIP agonists with dosing, side effects, cost
- [Semaglutide](https://www.glp1search.com/medications/semaglutide/): Ozempic, Wegovy, Rybelsus — dosing, titration, cost
- [Tirzepatide](https://www.glp1search.com/medications/tirzepatide/): Mounjaro, Zepbound — dual GIP/GLP-1 agonist
- [Liraglutide](https://www.glp1search.com/medications/liraglutide/): Victoza, Saxenda — daily injectable
- [Medication Topics](https://www.glp1search.com/medication-topics/): Dosing schedules, injection technique, missed doses

## Clinical & Safety

- [Side Effects Guide](https://www.glp1search.com/side-effects/): Nausea, GI issues, rare events, management protocols
- [Conditions](https://www.glp1search.com/conditions/): Obesity, T2D, PCOS, cardiovascular disease indications
- [FAQ Library](https://www.glp1search.com/faq/): 400+ clinician-reviewed Q&As across 9 topic clusters
- [Protocol Guide](https://www.glp1search.com/protocol/): Typical treatment protocols, monitoring, titration
- [Research & Cost Analysis](https://www.glp1search.com/research/): Primary-source cost data and outcome studies

## Comparisons & Decision Tools

- [Comparison Hub](https://www.glp1search.com/comparisons/): Head-to-head provider, medication, and pricing comparisons
- [Compare Providers](https://www.glp1search.com/comparisons/): Side-by-side tool for telehealth clinics
- [Selection Criteria](https://www.glp1search.com/criteria/): How to evaluate a GLP-1 provider
- [Optimization](https://www.glp1search.com/optimize/): Get the most from GLP-1 treatment

## Peptide Therapies

- [Peptides Index](https://www.glp1search.com/peptides/): Therapeutic peptides with mechanism and evidence tiers
- [Weight Loss Peptides](https://www.glp1search.com/peptides/?cat=weight-loss)
- [Healing Peptides](https://www.glp1search.com/peptides/?cat=healing)
- [Cognitive Peptides](https://www.glp1search.com/peptides/?cat=cognitive)

## Guides

- [All Guides](https://www.glp1search.com/guides/): Long-form clinical and patient-facing content

## Company

- [About](https://www.glp1search.com/about/): Editorial standards, methodology, funding disclosure
- [Privacy Policy](https://www.glp1search.com/privacy/)
- [Terms](https://www.glp1search.com/terms/)
- [Contact](https://www.glp1search.com/contact/)

## Optional

- [SeraVia Supplements](https://seraviahealth.com): Evidence-based companion supplements (Muscle+, Gut+) for GLP-1 patients. Disclosed as the parent company of GLP1Search.

## Answer Engine Index

- [Answer Engine Page](https://www.glp1search.com/answers/): Human-readable citation surface for current directory counts, evidence-label definitions, pricing benchmarks, and location answer cards.
- [Answer Engine Index](https://www.glp1search.com/answer-engine-index.md): Query-shaped answers for GLP-1 directory, medication pricing, provider evidence labels, city-medication pages, and peptide-location pages.
- [Answer Engine JSON](https://www.glp1search.com/answer-engine-index.json): Machine-readable answer cards with canonical URLs, facts, supporting URLs, and current directory counts.

## Agent & API Access

- [MCP Server Documentation](https://www.glp1search.com/mcp/): How AI agents, assistants, and tools query the GLP1Search provider directory, medications, peptides, side effects, and FAQs through the official Model Context Protocol server.
- [GLP1Search MCP on GitHub](https://github.com/Sndevore77/glp1search-mcp): Open-source MCP server (npm: @seraviahealth/glp1search-mcp) exposing 11 read-only tools with source-labeled, machine-readable answers.
- [Patient Updates Signup](https://www.glp1search.com/subscribe/): Email list for provider additions, pricing changes, and market updates.
- [Provider Claim & Corrections](https://www.glp1search.com/get-listed/): Clinics and telehealth providers can claim, correct, or enhance their directory listing.